Patience is truly needed by investors in CELZ if they want to maximize their ROI. This is not a stock to flip. Here's why:
1) CMTH has to my knowledge done everything correct with respect to best business practices. They have strategically worked step by step from product development, to patent filing, to successful trials at renowned institutions, to how they file in reasonably transparent manner. This is not by accident. These folks know what they are doing in order to build a new company from scratch to profitability in a challenging, expensive, competitive arena like bio-tech.
2) When launching any product or service, the first year is spent getting the word out, getting contracts signed, equipment purchased/installed, training completed to then finally start doing procedures. As new Urologists/Physicians are signed up and begin completing procedures, CELZ revenue will start compounding. I would not be surprised to have our latest $10K in revenue move to conservatively $50K plus next qtr, then $250k a qtr, then $1M a qtr, $10M a qtr until it's $50M a qtr or more. It takes time!
3) There are multiple revenue streams for Caverstem (procedure revenue, equipment purchase and kit revenue, maintenance revenue). As Caverstem is being rolled out over the next year CMTH will utilize their other patents as revenue multipliers. One year from now, CELZ revenue will be very strong and their share price will reflect that. The interesting piece will be from companies who may be looking to acquire CMTH (CELZ). They know what's going on in their universe and are watching every move CMTH makes. They will be watching closely this next quarter to see how everything plays out and then move accordingly.
When you look at the current share price at $.0185 or so and then take a look at how they are systematically starting to build out the revenue stream, it's not out of line to see their share price at $1 or more one year from now.
However, that brings us back to patience! I rarely post but read many. I don't get the impression a good percentage of folks posting on this board can wait a week, let alone give this a month or a year to blossom, which it will. If you plan to flip at $.04, you are literally missing the boat. I bought 4.2M shares on my second go around. When I see a CEO invest $140K of his money into buying 10M shares of his own stock, it's generally a good sign. Give this company some time. If you operate like someone on crack and need a fix every day, you will be disappointed. However, if you have patience and vision, this company appears to be doing everything the right way to give themselves the best chance of success. And other companies interested in potentially purchasing them are watching every move they make. The more buttoned up CELZ senior leadership is, the better it bodes for CELZ shareholders that a buyout could occur later in 2018. Then everyone can go Cha-Ching because you will have hit the jackpot.
Just my opinion after watching how this leadership team operates and how they keep things close to the vest, how they've taken Caverstem from infancy to commercialization and how they have been professional throughout. Good luck to all. I'm banking on them.
AI
